These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9399029)

  • 1. Pathogenesis of autosomal dominant polycystic kidney disease: recent developments.
    Grantham JJ
    Contrib Nephrol; 1997; 122():1-9. PubMed ID: 9399029
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberous sclerosis complex with autosomal dominant polycystic kidney disease: a rare duo.
    Rijal JP; Dhakal P; Giri S; Dahal KV
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of autosomal dominant polycystic kidney disease: role of apoptosis.
    Zhou XJ; Kukes G
    Diagn Mol Pathol; 1998 Apr; 7(2):65-8. PubMed ID: 9785003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease.
    Grantham JJ; Schreiner GF; Rome L; Grenz L; Joly A
    Proc Assoc Am Physicians; 1997 Jul; 109(4):397-408. PubMed ID: 9220537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of disease progression in rats with inherited polycystic kidney disease.
    Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
    Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.
    Poster D; Kistler AD; Krauer F; Blumenfeld JD; Rennert H; Weishaupt D; Wüthrich RP; Serra AL
    Am J Kidney Dis; 2009 Sep; 54(3):450-8. PubMed ID: 19515475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant polycystic kidney disease: cellular and molecular mechanisms of cyst formation.
    Wilson PD; Burrow CR
    Adv Nephrol Necker Hosp; 1992; 21():125-42. PubMed ID: 1566642
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical case of the month. Autosomal dominant polycystic kidney: factors in progression of renal insufficiency].
    Xhignesse P; Rorive G
    Rev Med Liege; 2000 Aug; 55(8):767-9. PubMed ID: 11051772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family with autosomal dominant polycystic kidney disease linked to 4q21-23.
    Jeffery S; Morgan S; Warmington VJ; MacGregor GA; Saggar-Malik AK
    J Med Genet; 1995 Jun; 32(6):493-4. PubMed ID: 7666409
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autosomal dominant (adult type) polycystic kidney disease].
    Higashihara E; Nutahara K
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1545-60. PubMed ID: 1722832
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging progression in polycystic kidney disease.
    Perrone R
    N Engl J Med; 2006 May; 354(20):2181-3. PubMed ID: 16707757
    [No Abstract]   [Full Text] [Related]  

  • 14. Autosomal recessive polycystic kidney disease does not map to the second gene locus for autosomal dominant polycystic kidney disease on chromosome 4.
    Zerres K; Mücher G; Rudnik-Schöneborn S
    Hum Genet; 1994 Jun; 93(6):697-8. PubMed ID: 8005596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Kidney Volume and Autosomal Dominant Polycystic Kidney Disease: A Long-Standing Relationship.
    Irazabal MV; Torres VE
    Am J Nephrol; 2018; 48(1):65-66. PubMed ID: 30071513
    [No Abstract]   [Full Text] [Related]  

  • 16. PKD and CF: an interesting family provides insight into the molecular pathophysiology of polycystic kidney disease.
    Cotton CU; Avner ED
    Am J Kidney Dis; 1998 Dec; 32(6):1081-3. PubMed ID: 9856528
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis of renal cysts in dominantly inherited polycystic kidney disease.
    Grantham JJ
    Contrib Nephrol; 1995; 115():16-9. PubMed ID: 8585907
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
    BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis.
    Higashihara E; Horie S; Kinoshita M; Harris PC; Okegawa T; Tanbo M; Hara H; Yamaguchi T; Shigemori K; Kawano H; Miyazaki I; Kaname S; Nutahara K
    Clin Exp Nephrol; 2018 Apr; 22(2):395-404. PubMed ID: 28983800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.